SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community eagerly anticipates imminent Phase 3 Regal trial results for its AML drug, GPS, and updates on SLS009, with many believing in a near-certain success and potential buyout by a major pharmaceutical company. This strong conviction, fueled by discussions of a significant short squeeze and the drug's 

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is actively discussed following its robust Q4 earnings beat and optimistic guidance, which highlighted record ARR growth and strong platform adoption in the evolving AI cybersecurity landscape, while the community remains divided on its high valuation and the sector's post-earnings performance.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following news of its significant senior secured notes offering to fund the Polaris Forge 2 AI campus, revealing Oracle as its tenant. Investors are actively discussing this non-dilutive funding and Oracle's confirmed strategic role, while eagerly anticipating further hyperscaler lease announcements to solidify APLD's position in the expanding AI infrastructure market.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

A sharp, unexpected sell-off in Indonesia Energy Corp Ltd (INDO) is fueling intense community debate, as it starkly defies surging crude oil prices and rallies in other energy stocks amidst escalating Middle East tensions. Investors are intensely discussing whether this rapid decline is market manipulation, dilution, or a temporary shakeout, with many drawing comparisons to its historically volatile behavior during past geopolitical events.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing high volatility as investors balance a new strategic partnership with Perplexity and broader tailwinds from OpenAI against concerns regarding its recent earnings report, which highlighted aggressive capital expenditure and profitability challenges. The community is sharply divided, with bulls buying the dip on strong AI demand and institutional backing, while bears point to debt and near-term profitability issues.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as it receives full notice to proceed on a $2.4 billion power generation project for Applied Digital's AI Factory campuses, a massive deal seen by the community as transformational for providing essential, rapidly deployable power solutions crucial for the growing artificial intelligence infrastructure.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab (GTLB) is trending after its Q4 earnings beat was overshadowed by disappointing FY27 growth guidance, leading to numerous analyst price target cuts. While bulls highlight a new $400 million share buyback and conservative management outlook, bears point to slowing growth and competitive pressures in the evolving AI-driven software development sector, leaving investors divided on its near-term trajectory and long-term valuation.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is trending after reporting strong Q4 earnings and a robust full-year outlook, marking thirteen consecutive quarters of growth and consistent double-digit operating margins. However, community discussion is mixed due to a softer Q1 guidance that has some investors speculating on a potential pullback, despite the company's significant share repurchase plans and continued brand momentum.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power Inc. is trending following its recent regulatory clearances for commercial graphene sales in the US, UK, and EU, sparking significant community excitement over its unique high-purity graphene and vast potential across critical sectors like defense and technology, with many anticipating major contracts and an uplisting to Nasdaq.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending following its settlement of major patent litigation, removing a significant financial overhang, while positive regulatory news on its combination COVID-flu vaccine and renewed FDA review for its seasonal flu shot fuels community discussion about a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Short Interest Down 24.5% in February

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 47,428 shares, a...

Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk

Adagene (NASDAQ:ADAG) highlighted updated details around its lead immuno-oncology program, ADG126, during an Oppenheimer discussion featuring Chief Strategy Officer Mickael Chane-Du. The company is...

Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders

MRNA shares jumped 5.3% as investors rotated into large-cap biotech, betting on its expanding pipeline in volatile trade.

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 283.2%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the recipient of a large increase in short interest in January. As of January 30th, there was short interest totaling 62,815 shares, an...

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Drops By 31.1%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 16,394...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm...

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 48.9%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 23,778 shares, a...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven ratings firms that are covering the company, Marketbeat...

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Declines By 36.8%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest...

FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug

Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Current Price	$2.97
Prev Close	$2.96
Open	$2.91
Dividend Yield	0.00%
50-Day Moving Average	$2.39
Beta	0.08
Avg. Volume	103,143.00
PE Ratio	-4.59

52-Week High	$3.53
52-Week Low	$1.30
Market Capitalization	$139.51M
EPS (Annual)	-$0.7426
Price to Book	3.68
Revenue Per Employee	$748.23

ADAG
Adagene Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest ADAG News

ADAGAdagene Inc - ADR